Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NACDS In Brief

This article was originally published in The Tan Sheet

Executive Summary

Bayer: Alka-Seltzer Plus Ready Release quick dissolve tablets slated to ship in early August, firm says at National Association of Chain Drug Stores Marketplace in San Diego June 8-10. New delivery form "melts in your mouth" with "no water needed," labeling notes. Tablets in blister-pack 12-count boxes contain acetaminophen and pseudoephedrine, will be indicated for nasal congestion, runny nose, sneezing and sinus pressure. Consumers are advised to take two tablets for symptom relief; flavors include cool mint and orange zest. Bayer will support the line extension with television and print ads, as well as FSI drops in October, November and December...

You may also be interested in...



Blistex Joins Spa Trend With Spa Effects Lip Balms

Blistex is tapping into the spa category with the introduction of Spa Effects lip protectant and sunscreen in a trio of "pampering" lip balms

Blistex Joins Spa Trend With Spa Effects Lip Balms

Blistex is tapping into the spa category with the introduction of Spa Effects lip protectant and sunscreen in a trio of "pampering" lip balms

Bayer Shuffle To Result In Increased Consumer Care Focus

Bayer expects the establishment of its healthcare operations as a separate business unit will allow an increased focus on its consumer care business, CEO Werner Wenning said in a Nov. 11 earnings call

Related Content

Topics

UsernamePublicRestriction

Register

PS095610

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel